Skip to content
Enliven Therapeutics, Inc. (ELVN) Stock Price, Key Stats & Insider Trading
Home / Companies / ELVN ELV
Enliven Therapeutics, Inc. (ELVN) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest ELVN Insider Trades
About Enliven Therapeutics, Inc. (ELVN) Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Headquarters BURLINGAME, CA
Employees 67
Listed 2023
Exchange XNAS https://www.enliventherapeutics.com SEC filings for ELVN on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 32 1,353,380 $63.80M Option exercise 18 361,770
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
ELVN Insider Transactions (Form 4) 66 83 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 3 of 3.
Date Insider Transaction Security Shares Price Value Jun 27, 2025 BH Benjamin Hohl - Officer Option exercise Common Stock
Recent ELVN Form 8-K Filings 5
Recent ELVN Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 4, 2026 Derynck Mika K Director 158,795 $9.22M View on EDGAR Jul 17, 2026 - -
ELVN Insider Trading - FAQ
What is the latest insider trade for ELVN? Enliven Therapeutics, Inc. (ELVN) had 11 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for ELVN runs to 83 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying ELVN stock? No insider purchases of ELVN were filed in the last 90 days.
How many insiders are selling ELVN stock? 32 insider sales of ELVN were filed in the last 90 days, totaling $63.80M.
Where can I see ELVN SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks ELVN Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow ELVN insider buys? Create a free InsiderAlpha account and press Watch on this page to add ELVN to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track ELVN insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free - Officer
Market cap $4.24B
P/E ratio -
Dividend yield -
Average volume 1.41M
52 week high $62.32
52 week low $14.79
Today's high $61.18
Today's low $57.73
Open $60.40
Volume 585.0K
Previous close $60.50
Shares outstanding 73.27M Market cap
$4.24B
67 employees
ELVN Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 32 sales totaling $63.80M.
Most-Active ELVN Insiders - Last 90 Days 10 Jun 27, 2025 BH Benjamin Hohl - Officer Open-market sale Common Stock 3,052 $20.86 $64K
Jun 27, 2025 BH Benjamin Hohl - Officer Open-market sale Common Stock 198 $21.66 $4K
Jun 27, 2025 BH Benjamin Hohl - Officer Option exercise Stock Option (right to buy) 3,250 $0.00 -
Dec 27, 2024 BH Benjamin Hohl - Officer Option exercise Common Stock 3,350 $2.48 $8K
Dec 27, 2024 BH Benjamin Hohl - Officer Open-market sale Common Stock 3,350 $22.15 $74K
Dec 30, 2024 BH Benjamin Hohl - Officer Option exercise Common Stock 900 $2.48 $2K
Dec 30, 2024 BH Benjamin Hohl - Officer Open-market sale Common Stock 900 $22.51 $20K
Dec 27, 2024 BH Benjamin Hohl - Officer Option exercise Stock Option (right to buy) 3,350 $0.00 -
Dec 30, 2024 BH Benjamin Hohl - Officer Option exercise Stock Option (right to buy) 900 $0.00 -
Nov 27, 2024 BH Benjamin Hohl - Officer Option exercise Common Stock 5,250 $2.48 $13K
Nov 27, 2024 BH Benjamin Hohl - Officer Open-market sale Common Stock 4,250 $24.78 $105K
Nov 27, 2024 BH Benjamin Hohl - Officer Open-market sale Common Stock 1,000 $25.38 $25K
Nov 27, 2024 BH Benjamin Hohl - Officer Option exercise Stock Option (right to buy) 5,250 $0.00 -
Oct 28, 2024 BH Benjamin Hohl - Officer Option exercise Common Stock 6,250 $2.48 $16K
Oct 28, 2024 BH Benjamin Hohl - Officer Open-market sale Common Stock 5,600 $28.49 $160K
Oct 28, 2024 BH Benjamin Hohl - Officer Open-market sale Common Stock 650 $29.11 $19K
Oct 28, 2024 BH Benjamin Hohl - Officer Option exercise Stock Option (right to buy) 6,250 $0.00 -
Oct 18, 2024 SK Samuel Kintz - Officer Open-market sale Common Stock 924 $30.00 $28K
Oct 18, 2024 BH Benjamin Hohl - Officer Option exercise Common Stock 814 $2.48 $2K
Oct 18, 2024 BH Benjamin Hohl - Officer Open-market sale Common Stock 814 $30.00 $24K
Oct 18, 2024 BH Benjamin Hohl - Officer Option exercise Stock Option (right to buy) 814 $0.00 -
Oct 18, 2024 AP Anish Patel - Officer Open-market sale Common Stock 716 $30.00 $21K
Oct 8, 2024 RB Rahul D. Ballal Option exercise Stock Option (right to buy) 6,314 $0.00 -
Oct 8, 2024 RB Rahul D. Ballal Option exercise Stock Option (right to buy) 4,106 $0.00 -
Oct 8, 2024 SK Samuel Kintz - Officer Open-market sale Common Stock 13,167 $27.95 $368K
Oct 8, 2024 SK Samuel Kintz - Officer Open-market sale Common Stock 100 $28.51 $3K
Oct 9, 2024 SK Samuel Kintz - Officer Open-market sale Common Stock 13,880 $28.07 $390K
Oct 9, 2024 SK Samuel Kintz - Officer Open-market sale Common Stock 2,830 $28.53 $81K
Oct 4, 2024 SK Samuel Kintz - Officer Open-market sale Common Stock 12,206 $27.51 $336K
Oct 7, 2024 SK Samuel Kintz - Officer Open-market sale Common Stock 2,730 $27.50 $75K
Oct 4, 2024 BH Benjamin Hohl - Officer Option exercise Common Stock 10,218 $2.48 $25K
Oct 4, 2024 BH Benjamin Hohl - Officer Open-market sale Common Stock 10,218 $27.51 $281K
Oct 7, 2024 BH Benjamin Hohl - Officer Option exercise Common Stock 1,270 $2.48 $3K
Oct 7, 2024 BH Benjamin Hohl - Officer Open-market sale Common Stock 1,270 $27.51 $35K
Oct 4, 2024 BH Benjamin Hohl - Officer Option exercise Stock Option (right to buy) 10,218 $0.00 -
Oct 7, 2024 BH Benjamin Hohl - Officer Option exercise Stock Option (right to buy) 1,270 $0.00 -
Oct 1, 2024 BH Benjamin Hohl - Officer Option exercise Common Stock 521 $2.48 $1K
Oct 1, 2024 BH Benjamin Hohl - Officer Open-market sale Common Stock 521 $27.54 $14K
Oct 1, 2024 BH Benjamin Hohl - Officer Option exercise Stock Option (right to buy) 521 $0.00 -
Oct 1, 2024 SK Samuel Kintz - Officer Open-market sale Common Stock 526 $27.54 $14K
Sep 27, 2024 BH Benjamin Hohl - Officer Option exercise Common Stock 4,250 $2.48 $11K
Sep 27, 2024 BH Benjamin Hohl - Officer Open-market sale Common Stock 4,250 $24.27 $103K
Sep 30, 2024 BH Benjamin Hohl - Officer Option exercise Common Stock 2,000 $2.48 $5K
Sep 30, 2024 BH Benjamin Hohl - Officer Open-market sale Common Stock 2,000 $25.33 $51K
Sep 27, 2024 BH Benjamin Hohl - Officer Option exercise Stock Option (right to buy) 4,250 $0.00 -
Sep 30, 2024 BH Benjamin Hohl - Officer Option exercise Stock Option (right to buy) 2,000 $0.00 -
$EOLS
Evolus, Inc.
$ELAN
Elanco Animal Health Inc
Benjamin Hohl - OfficerOpen-market sale$270K
